A phase 2 study evaluates the safety and efficacy of brentuximab vedotin and nivolumab plus chemotherapy in patients with early-stage classical Hodgkin lymphoma.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/immunotherapy-combo-shows-promise-hodgkin-lymphoma-2026a1000c8x?src=rss
Author :
Publish date : 2026-04-20 04:23:00
Copyright for syndicated content belongs to the linked Source.
